AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Yahoo! Finance
Sales and Marketing Expenses: About $3 million, a small reduction from last year. General and Administration Expenses: Approximately $19 million, up from $14 million in Q3 2023. Net Loss: Roughly $51 million for the quarter, compared to a loss of nearly $29 million in the same quarter last year. Earnings Per Share: Loss of $0.17 per share on a basic and diluted basis. Cash and Equivalents: Approximately $670 million at the end of the quarter. Cash Used in Operations: Approximately $100 million for the first nine months of 2024. Short-term Marketable Securities: Nearly $520 million invested. Total Available Liquidity: Approximately $880 million, including unused government funding. Warning! GuruFocus has detected 6 Warning Signs with ABCL. Release Date: November 04, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript AbCellera Biologics Inc ( NASDAQ:ABCL ) is on track to file CTA for its first two internal pipe
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- AbCellera to Present at Upcoming Investor Conferences in December and January [Yahoo! Finance]Yahoo! Finance
- AbCellera to Present at Upcoming Investor Conferences in December and JanuaryBusiness Wire
- AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024Business Wire
- AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]Yahoo! Finance
ABCL
Earnings
- 11/4/24 - Miss
ABCL
Sec Filings
- 11/14/24 - Form SC
- 11/4/24 - Form 10-Q
- 11/4/24 - Form 8-K
- ABCL's page on the SEC website